在患有肺癌的患者中比较不同可穿戴活动监视器的准确性,并提供初步建议:试点验证研究的协议
Roberto M Benzo1, Rujul Singh1, Carolyn J Presley2
1Division of Cancer Prevention and Control, Department of Internal Medicine, The Ohio State Comprehensive Cancer Center, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
JMIR research protocols
|June 19, 2025
概括
这项研究对肺癌患者的可穿戴活动监测器 (WAM) 进行了验证,为这一群体准确评估身体活动建立了框架. 这些发现将指导未来的癌症幸存者的研究和干预.
科学领域:
- 生物医学工程 生物医学工程
- 临床研究 临床研究
- 康复科学 康复科学 康复科学
背景情况:
- 可穿戴活动监测器 (WAM) 对于评估癌症生存率的身体活动 (PA) 是至关重要的,但在肺癌 (LC) 患者群体中缺乏验证.
- 患有LC的患者往往有影响WAM准确性的运动障碍,突出了关键的研究差距.
- 对于具有独特生理挑战的癌症患者群体的WAM验证,需要标准化.
研究的目的:
- 在LC患者中验证和比较消费者 (Fitbit Charge 6) 和研究级 (activPAL3 micro,ActiGraph LEAP) WAM.
- 建立在癌症群体中WAM验证的标准化协议,并考虑疾病特异性因素.
- 在受控实验室和自由生活条件下评估WAM准确性.
主要方法:
- 在实验室和7天自由生活协议期间,15名患有LC (1-4阶段) 的成年人将同时佩戴3个WAM.
- 实验室验证涉及结构化活动 (走路,姿势变化) 与视频记录相比.
- 自由生活评估包括持续的磨损,用Bland-Altman图表和类内相关性分析步骤,PA强度和姿势的数据.
主要成果:
- 数据收集正在进行中,目前有11名参与者注册,7人正在完成协议.
- 注册参与者的平均年龄为63.0年 (SD 7.8),其中73%为女性.
- 预计到2025年中期将全面招生,预计到2025年底将有初步调查结果.
结论:
- 这项研究是第一个专门针对肺癌人群验证WAM准确性的研究.
- 它将为未来类似队列中的WAM验证研究提供全面的建议.
- 结果对于准确的PA评估,临床研究解释和为LC幸存者开发有针对性的干预措施至关重要.
关键词:
这就是ActiGraph.这是Fitbit的Fitbit.活动PAL3微型癌症的生存率 癌症的生存率消费者技术的消费者技术数字健康数字健康肺癌是一种肺癌.身体活动监测 身体活动监测验证研究的验证研究.可穿戴设备可穿戴设备.更多相关视频
相关概念视频
01:20Assessment of Ventilation I: Respiratory Rate
Assessment of Ventilation
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:23Holter Monitor: 24-Hour Monitoring
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...